Kymera Therapeutics, Inc.
2021 Q3 - 2025 Q4 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 1,216 | 0.0% | 15,631 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 840 | 0.0% | 14,842 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 579 | 0.0% | 13,259 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 311 | 0.0% | 11,348 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 481 | 0.0% | 11,954 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 534 | 0.0% | 11,289 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 310 | 0.0% | 10,374 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 417 | 0.0% | 10,375 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 154 | 0.0% | 6,040 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 84 | 0.0% | 6,040 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 139 | 0.0% | 6,040 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 179 | 0.0% | 6,040 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 124 | 0.0% | 4,985 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 82 | 0.0% | 3,760 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 74 | 0.0% | 3,760 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 159 | 0.0% | 3,760 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 208 | 0.0% | 3,272 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 106 | 0.0% | 1,805 | 9/30/2021 |